Prediction of survival benefit when deciding between chemotherapy and best supportive therapy in elderly patients with advanced gastric cancer: A retrospective cohort study.

Mol Clin Oncol · 2019 · PMC6313942 · PMID 30655981

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP<0.0001actually significant

There was a highly significant difference in OS between chemotherapy and BSC in non-EPs (10.8 vs. 1.6 months, respectively; P<0.0001), as well as in EPs (6.6 vs. 2.8 months, respectively; P=0.0069).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.